Candestra Capital is a privately held investment firm founded and led by Dimitrios Paolo. It operates under Candestra Ltd., and its objective is to compound capital at an attractive rate of return by deploying proprietary capital into high-conviction opportunities through equity stakes or asset-specific vehicles. We follow a value-oriented philosophy, seeking complexity that is mispriced or misunderstood. Where conviction is high and inefficiency is clear, we size significantly. Because true opportunities are rare, we operate with a long-term time horizon and a willingness to remain inactive when nothing meets our standards. Candestra Capital currently invests proprietary capital. Future partners must be deeply aligned with this approach.
| Report Title | Company | Ticker | Date | Sector |
|---|---|---|---|---|
| Why I’m Short INmune Bio | INmune Bio, Inc. | NASDAQ: INMB | 2025-Jun-23 | Biotechnology |
| Intel's Silent Revival That Only a Few Can See | Intel Corporation | NASDAQ: INTC | 2025-Jan-16 | Technology |
| The Insane Hype Of Retail Traders Gambling The Stock Market | Robinhood Markets, Inc. | NASDAQ: HOOD | 2024-Sep-06 | Financials |